AS

Angha Sanjay Apte

Active Director Director DIN 07357635
DIN 07357635 First appointment Sep 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2014
Shareholding value •••• Premium profile

About Angha Sanjay Apte

Data last updated:

Angha Sanjay Apte is a Director at Medtabs Pharma Private Limited (since 2014). The company operates in Healthcare. Medtabs Pharma Private Limited reported revenue of ₹2.71 Cr (FY 2024).

DIN 07357635
Primary Designation Director
Industry Healthcare
First Appointment 27 Sep 2014
Oldest Company Age 12 yrs
Largest company Medtabs Pharma Private Limited · ₹2.71 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medtabs Pharma Private Limited U85100PN2014PTC151685
Director27 Sep 20142014₹2.71 Cr (FY 2024)Active

Board colleagues of Angha Sanjay Apte

Directorship timeline

Open interactive timeline →
Medtabs Pharma Private Limited
Premium access

Shareholding and investment profile for Angha Sanjay Apte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Angha Sanjay Apte

Angha Sanjay Apte currently holds 1 directorship: Medtabs Pharma Private Limited (Director, since 27 Sep 2014, revenue ₹2.71 Cr (FY 2024)).

Angha Sanjay Apte was first appointed on 27 Sep 2014 as Director at Medtabs Pharma Private Limited.

The current boards of Angha Sanjay Apte's companies include Prashant Ganpati Wankar (Medtabs Pharma Private Limited), Sagar Pramod Doshi (Medtabs Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available